ISOLATED MYELOSARCOMA TREATED AS AML, WITH PROGRESSION TO MDS/MPN

被引：0
|
作者：
Fuentes, A. [1 ]
LaBier, G. [2 ]
Boulmay, B. [1 ]
机构：
[1] LSU Hlth Sci Ctr, Metairie, LA USA
[2] LSU, New Orleans, LA USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2018年 / 66卷 / 02期
关键词：
D O I：
10.1136/jim-2017-000697.217
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
217
引用
收藏
页码：440 / 440
页数：1
相关论文
共 50 条
  • [21] Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
    A Tefferi
    K-H Lim
    O Abdel-Wahab
    T L Lasho
    J Patel
    M M Patnaik
    C A Hanson
    A Pardanani
    D G Gilliland
    R L Levine
    Leukemia, 2009, 23 : 1343 - 1345
  • [22] MDS/MPN Overlap Syndromes
    Padron, Eric
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S22 - S22
  • [23] Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS
    Gupta, Vikas
    Kim, Soyoung
    Hu, Zhen-Huan
    Liu, Ying
    Aljurf, Mahmoud
    Bacher, Ulrike
    Beitinjaneh, Amer
    Cahn, Jean-Yves
    Cerny, Jan
    Copelan, Edward
    Gadalla, Shahinaz M.
    Gale, Robert Peter
    Ganguly, Siddhartha
    George, Biju
    Gerds, Aaron T.
    Gergis, Usama
    Hamilton, Betty K.
    Hashmi, Shahrukh
    Hildebrandt, Gerhard C.
    Kamble, Rammurti T.
    Kindwall-Keller, Tamila
    Lazarus, Hillard M.
    Liesveld, Jane L.
    Litzow, Mark
    Maziarz, Richard T.
    Nishihori, Taiga
    Olsson, Richard F.
    Rizzieri, David
    Savani, Bipin N.
    Seo, Sachiko
    Solh, Melhem
    Szer, Jeff
    Verdonck, Leo F.
    Wirk, Baldeep
    Woolfrey, Ann
    Yared, Jean A.
    Alyea, Edwin P.
    Popat, Uday R.
    Sobecks, Ronald M.
    Scott, Bart L.
    Nakamura, Ryotaro
    Saber, Wael
    BLOOD ADVANCES, 2020, 4 (19) : 4748 - 4757
  • [24] Karyotype evolution and AML progression in 163 myelodysplastic syndromes (MDS)
    Bernasconi, F.
    Boni, M.
    Cavigliano, P. M.
    Giardini, I
    Zappatore, R.
    Calabroni, S.
    Rocca, B.
    Dambruoso, I
    Caresana, M.
    Astori, C.
    Lazzarino, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 158 - 158
  • [25] Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
    Jiang, Ying
    Dunbar, Andrew
    Gondek, Lukasz P.
    Mohan, Sanjay
    Rataul, Manjot
    O'Keefe, Christine
    Sekeres, Mikkael
    Saunthararajah, Yogen
    Maciejewski, Jaroslaw P.
    BLOOD, 2009, 113 (06) : 1315 - 1325
  • [26] A Prognostic Scoring System for Unclassifiable MDS and MDS/MPN
    Liu, Yang
    Tabarroki, Ali
    Visconte, Valeria
    Hasrouni, Edy
    Bupathi, Manoj
    Hamilton, Betty K.
    Traina, Fabiola
    Duong, Hien K.
    Rogers, Heesun J.
    Saunthararajah, Yogen
    Komrokji, Rami S.
    Sekeres, Mikkael A.
    Tiu, Ramon V.
    BLOOD, 2012, 120 (21)
  • [27] A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide
    Islam, Anwarul
    CLINICAL CASE REPORTS, 2015, 3 (07): : 551 - +
  • [28] Isolated myelosarcoma of the skin in childhood
    Reinhardt, D
    Pekrun, A
    Lakomek, M
    Ritter, J
    Creutzig, U
    MONATSSCHRIFT KINDERHEILKUNDE, 1999, 147 (04) : 346 - 350
  • [29] SINGLE-CENTER EXPERIENCE OF AZACITIDINE-VENETOCLAX IN SECONDARY ACUTE MYELOID LEUKEMIA (AML), ARISING FROM MYELODYSPLASTIC SYNDROME (MDS), MYELOPROLIFERATIVE NEOPLASM (MPN) OR MDS/MPN OVERLAP
    Halim, N. A. Abdul
    Chan, T. W.
    Wong, G. C.
    Than, H.
    LEUKEMIA RESEARCH, 2023, 128
  • [30] Acquired Somatic Uniparental Disomy is a Chromosomal Defect Important in Predicting Treatment Responses and Survival Outcomes in MDS, MDS/MPN and Secondary AML
    Tiu, Ramon V.
    O'Keefe, Christine
    Gondek, Lukasz P.
    Mohamedali, Azim M.
    Przychodzen, Bartlomiej P.
    Mufti, Ghulam J.
    Sekeres, Mikkael A.
    Advani, Anjali S.
    McDevitt, Michael A.
    Maciejewski, Jaroslaw P.
    BLOOD, 2009, 114 (22) : 1032 - 1032
12345